Alpha Cubed Investments’s Novartis NVS Stock Holding History

Alpha Cubed Investments’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-3,221	Closed	-$242K	–	238
2017 Q4	$242K	Hold	3,221	–	–	0.03%	205
2017 Q3	$248K	Buy	+3,221	New	+$243K	0.04%	189
2016 Q1	–	Sell	-13,236	Closed	-$1.02M	–	181
2015 Q4	$1.02M	Sell	13,236 -172	-1%	-$13.7K	0.27%	77
2015 Q3	$1.09M	Buy	13,408 +39	+0.3%	+$3.47K	0.28%	75
2015 Q2	$1.18M	Sell	13,369 -167	-1%	-$15.3K	0.32%	79
2015 Q1	$1.2M	Sell	13,536 -2,395	-15%	-$212K	0.37%	74
2014 Q4	$1.32M	Sell	15,931 -586	-4%	-$48.6K	0.52%	58
2014 Q3	$1.39M	Sell	16,517 -669	-4%	-$54.1K	0.66%	51
2014 Q2	$1.39M	Sell	17,186 -686	-4%	-$54K	0.62%	58
2014 Q1	$1.36M	Sell	17,872 -18,743	-51%	-$1.37M	0.71%	50
2013 Q4	$2.64M	Buy	+36,615	New	+$2.55M	0.94%	24

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Alpha Cubed Investments's NVS Position: Q1 2018 in Review

Alpha Cubed Investments sold out of Novartis (NVS) in Q1 2018, closing a stake of 3,221 shares — an estimated $242K sold.

Alpha Cubed Investments first reported a position in NVS in Q4 2013 and held it in 11 quarters. The position peaked at $2.64M in Q4 2013. 1,012 funds tracked by Wall St. Rank hold NVS as of Q1 2018.

Alpha Cubed Investments reported no remaining Novartis position as of Q1 2018 after selling out during the quarter.
Alpha Cubed Investments sold 3,221 Novartis shares in Q1 2018, an estimated $242K.
Alpha Cubed Investments first reported a position in Novartis in Q4 2013 and held it in 11 quarters.
Alpha Cubed Investments's Novartis position peaked at $2.64M in Q4 2013.
1,012 funds tracked by Wall St. Rank held Novartis as of Q1 2018.

Based on Alpha Cubed Investments's 13F filing for Q1 2018, filed 9 May 2018.